![Benoit Bouche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Benoit Bouche is currently the Chief Executive Officer at Pacific Biomarkers, Inc., the President, Chief Executive Officer & Director at Nexelis Laboratories Canada, Inc., and the Operating Partner at Ampersand Management LLC.
He previously served as the President & Chief Executive Officer at NEOMED-LABS, Inc. and as an Analyst at Puilaetco in 2001.
Postes actifs de Benoit Bouche
| Sociétés | Poste | Début |
|---|---|---|
Pacific Biomarkers, Inc.
 Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Provides biomarker testing services | Directeur Général | - |
Nexelis Laboratories Canada, Inc.
 Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Directeur Général | 01/01/2017 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Private Equity Investor | 01/04/2022 |
Anciens postes connus de Benoit Bouche
| Sociétés | Poste | Fin |
|---|---|---|
Puilaetco
 Puilaetco Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 05/12/2001 |
NEOMED-LABS, Inc.
 NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Puilaetco
Puilaetco Investment Banks/BrokersFinance Provides brokerage services | Finance |
NEOMED-LABS, Inc.
NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pacific Biomarkers, Inc.
Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Provides biomarker testing services | Health Technology |
Nexelis Laboratories Canada, Inc.
Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Health Technology |
